Merck’s Timoptic XE
Executive Summary
Long-acting timolol maleate gel formulation is "approvable" June 24 for lowering of intraocular pressure in glaucoma patients. Timoptic XE will allow once-a-day dosing compared to the twice- daily dosing of Timoptic solution.